Analytical Data
-
基因名
Blot21
-
简介
Blot21 Protein, representing a new group of allergens, is an important Blomia tropicalis allergen. Allergenic components from Blomia tropicalis are important triggers of allergies in the tropics. Blot21 is a paralog of the group 5 allergen Blot5. Blot21 has moderate sequence identity (40.7%) to Blot5 and low to moderate cross-reactivity to Blot5. Blot21 Protein, Blomia tropicalis (HEK293, His) is the recombinant Blot21 protein, expressed by HEK293 , with N-6*His labeled tag.
- Application
-
别名
Mite allergen Blo t 21; Mite group 21 allergen Blo t 21; Blo t 21
-
种属
Others
-
表达系统
HEK293
-
标签
N-6*His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
AAX34047
-
表达区间
L17-E129
-
蛋白长度
Partial
-
分子量
16.3 kDa.
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Ficolin-1, a collagen-like lectin, plays a crucial role in the innate immune system by recognizing and binding to specific carbohydrates on pathogens, facilitating their elimination through opsonization and complement activation. Its unique structure, which combines a carbohydrate recognition domain with a fibrinogen-like domain, allows for the mediation of immune responses and interaction with various cells of the immune system. Research into recombinant Ficolin-1 protein has gained momentum due to its potential therapeutic applications, including the development of novel immunotherapies and diagnostics. Studies have shown that recombinant Ficolin-1 can enhance phagocytosis and modulate inflammatory responses, making it a valuable candidate for further investigation in conditions such as infections, autoimmune disorders, and cancer. Understanding its functional mechanisms could lead to innovative approaches in harnessing the immune system, thereby paving the way for new strategies in disease management. As researchers delve deeper into its molecular pathways and interactions, the promise of Ficolin-1 in clinical applications continues to expand, highlighting the significance of this protein in immunological research.
